Inventaire - your friends and communities are your best library

Optimal treatment of early-stage ovarian cancer

published in: Annals of Oncology

date of publication: 2014-03-14

main subject: ovarian cancer

Cites articles 23

Date

Title

Authors

2011-05-06

A randomized phase III trial of IV carboplatin and paclitaxel × 3 courses followed by observation versus weekly maintenance low-dose paclitaxel in patients with early-stage ovarian carcinoma: a Gynecologic Oncology Group Study

David E. Cohn, Helen E. B. Michael, Bradley J. Monk
2010-11-01

Platinum-based adjuvant chemotherapy for early-stage epithelial ovarian cancer: single or combination chemotherapy?
2010-05-05

Surgical staging and treatment of early ovarian cancer: long-term analysis from a randomized trial
2010-08-23

Phase III trial of carboplatin plus paclitaxel with or without gemcitabine in first-line treatment of epithelial ovarian cancer,Phase III Trial of Carboplatin Plus Paclitaxel With or Without Gemcitabine in First-Line Treatment of Epithelial Ovarian Cancer
2010-01-13

Understanding the problem of inadequately staging early ovarian cancer

Ignace Vergote
2009-04-01

Current FIGO staging for cancer of the vagina, fallopian tube, ovary, and gestational trophoblastic neoplasia
2009-01-21

Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer

Heather O. Dickinson
2009-09-18

Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial

Daisuke Aoki, Toru Sugiyama, Noriyuki Katsumata
2008-03-18

The treatment and outcomes of early-stage epithelial ovarian cancer: have we made any progress?
2008-05-01

Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study

Bradley J. Monk
2006-07-24

Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study
2006-11-01

Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

Patrick Maisonneuve
2006-09-01

Time to include high-risk early ovarian cancer in randomized phase III trials of advanced ovarian cancer

Ignace Vergote, Frédéric Amant
2003-01-01

International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma

Ignace Vergote
2003-01-01

Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial

Ignace Vergote
2003-01-01

International Collaborative Ovarian Neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer
2002-08-01

Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial
2002-08-01

Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects

Patrick Royston
2001-01-01

Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma.

Anthony Fyles, Claes Göran Tropé, Dirk Timmerman, Ignace Vergote
2000-07-01

Ovarian cancer: epidemiology, biology, and prognostic factors
1999-02-01

Risk of leukemia after platinum-based chemotherapy for ovarian cancer

Tom Wiklund, Per Hall, Marilyn Stovall
1990-04-01

Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials
1983-12-01

Staging laparotomy in early ovarian cancer,Staging Laparotomy in Early Ovarian Cancer

Article - wd:Q33683114

Welcome to Inventaire

the library of your friends and communities

learn more